Nicholas Argento, MD, FACE
Maryland Endocrine, Columbia, Maryland, USA
Dr Argento is a senior clinical endocrinologist at the Maryland Endocrine and Diabetes Center in Columbia, Maryland, where he serves as the Diabetes Technology Director. His practice emphasizes the implementation of advanced diabetes technology to improve the lives of those with insulin requiring diabetes. He co-authored multiple chapters in the American Diabetes Association 2013 book, “Putting Your Patients on the Pump,” and was primary investigator for 3 published retrospective studies on clinical aspects of CGM use, and was first author of a T1D Exchange publication on the impact of Medicare pump policies on patient care (J Diab Sci Tech 2020, Vol. 14(2) 257–261). He has presented on CGM and diabetes technology at ADA, EASD, AACE, and Diabetes Technology Society scientific sessions, and spoken to regional, national and international audiences on CGM and insulin pump use.